Logo, Renata Stripecke Lab, Lymphoid Cell Thearpy Laboratory Lymphoid Cell Therapy Laboratory


Research

Virus Our task is the understanding and targeted manipulation of the immune system to be applied in the cure of human diseases. Our approach is to genetically program blood cells with designed viral vectors, such that they can be used in the treatment of diseases like cancer and chronic infections, where the immune responses have been severely abrogated. We utilize lentiviral vectors derived from HIV-1 that deliver ectopic expression of cytokines and antigens into hematopoietic precursors, which are then capable to self-differentiate into dendritic cells, which are powerful antigen presenting cells. This concept is currently being developed for immunotherapy of melanoma, leukemia and AIDS.


Research Aims:

  • To program hematopoietic precursors / stem cells with designed lentiviral vectors to yield highly viable, potent and safe dendritic cells.
  • To utilize programmed DCs for in vitro priming and expansion of T cells reactive against specific tumor and viral antigens.
  • To evaluate the engraftment, viability, migratory potential and potency of ex vivo generated dendritic cells and T cells in preclinical animal models.
  • To translate this know-how into active (dendritic cells) and adoptive immunotherapy (T cells) approaches for cancer and infectious diseases.
  • To undestand the effects of oncogenes and viral proteins in the development of functional dendritic cells.

Schema of Gene Therapy Research
Schema of Gene Therapy Research


© dw-websites
Scientific Webdesign Hannover


Home I Imprint I Contact

Medical School Hannover
Dept. of Hematology, Hemostasiology and Oncology
Carl-Neuberg-Strasse 1
OE6860 - HBZ
D-30625 Hannover, Germany